- Home
- SERA vs GECC Comparison
SERA vs GECC Comparison
Compare SERA & GECC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SERA | GECC |
|---|---|---|
| Founded | 2008 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.2M | 84.6M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | SERA | GECC |
|---|---|---|
| Price | $2.02 | $5.43 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $10.75 |
| AVG Volume (30 Days) | 40.4K | ★ 101.2K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 22.06% |
| EPS Growth | ★ 32.32 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $81,000.00 | N/A |
| Revenue This Year | $554.81 | $0.92 |
| Revenue Next Year | $517.27 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 5.19 | N/A |
| 52 Week Low | $1.56 | $4.63 |
| 52 Week High | $3.95 | $11.45 |
Technical Indicators
Market Signals| Indicator | SERA | GECC |
|---|---|---|
| Relative Strength Index (RSI) | 54.72 | 37.71 |
| Support Level | $1.85 | $4.74 |
| Resistance Level | $2.03 | $5.37 |
| Average True Range (ATR) | 0.14 | 0.27 |
| MACD | 0.01 | -0.04 |
| Stochastic Oscillator | 75.34 | 0.96 |
Price Performance
Historical ComparisonAbout SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
About GECC Great Elm Capital Corp.
Great Elm Capital Corp is an externally managed, non-diversified closed-end management investment company. It generates both income and capital appreciation through debt and income-generating equity investments, including investments in finance businesses. The Company operates as a single reportable segment with an investment objective to generate both current income and capital appreciation through debt and equity investments and manages the business on a consolidated basis.